Kazia (ASX:KZA) share price slides despite positive update

kazia asxkza share price slides despite positive update

Sumary of Kazia (ASX:KZA) share price slides despite positive update:

  • In its announcement, Kazia shared some key points of its ongoing phase II study of paxalisib in glioblastoma – a common and very aggressive type of brain cancer..
  • Kazia noted that the data is subject to a poster presentation at the Association of Cancer Research (AACR) annual meeting..
  • More broadly, the phase II study is drawing to a conclusion, and we expect to be able to share final data in the second half of this year..
  • Kazia share price summary Over the past 12 months, the Kazia share price has soared more than 300%, reflecting positive investor sentiment….

Want to know more click here go to source.

From -
Close
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close